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Abstract
Positive selection is known to occur when the environment that an organism inhabits is suddenly altered, as is the case
across recent human history. Genome-wide association studies (GWASs) have successfully illuminated disease-associated
variation. However, whether human evolution is heading towards or away from disease susceptibility in general remains an
open question. The genetic-basis of common complex disease may partially be caused by positive selection events, which
simultaneously increased fitness and susceptibility to disease. We analyze seven diseases studied by the Wellcome Trust
Case Control Consortium to compare evidence for selection at every locus associated with disease. We take a large set of
the most strongly associated SNPs in each GWA study in order to capture more hidden associations at the cost of
introducing false positives into our analysis. We then search for signs of positive selection in this inclusive set of SNPs. There
are striking differences between the seven studied diseases. We find alleles increasing susceptibility to Type 1 Diabetes
(T1D), Rheumatoid Arthritis (RA), and Crohn’s Disease (CD) underwent recent positive selection. There is more selection in
alleles increasing, rather than decreasing, susceptibility to T1D. In the 80 SNPs most associated with T1D (p-value
,7.01610
25) showing strong signs of positive selection, 58 alleles associated with disease susceptibility show signs of
positive selection, while only 22 associated with disease protection show signs of positive selection. Alleles increasing
susceptibility to RA are under selection as well. In contrast, selection in SNPs associated with CD favors protective alleles.
These results inform the current understanding of disease etiology, shed light on potential benefits associated with the
genetic-basis of disease, and aid in the efforts to identify causal genetic factors underlying complex disease.
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Introduction
Humans have gone from existing solely in Africa to inhabiting
every continent on Earth [1]. More recently, humans have begun
cultivating specialized food-crop, domesticating animals, and
living in towns and cities. Such environmental changes are known
to alter common genetic variation via the positive selection of
advantageous mutations [2]. As many populations were exposed to
new food sources, diseases, and cultural lifestyles, positive selection
likely played a major role in shaping the genetic architecture. A
positive selection event represents a net gain of fitness, and there is
room for the simultaneous selection of harmful mutations if they
are linked to a relatively strongly beneficial mutation [3]. This can
occur when a locus is in linkage disequilibrium (LD) with a
beneficial mutation. Alternatively, the beneficial mutation may
simultaneously harbor a harmful component [4]. Positive selection
may occur as long as the benefits outweigh the harm. Therefore,
increased susceptibility to disease may accompany a fitness-
increasing mutation introduced by positive selection.
Complex diseases contain many distinct associations across the
human genome that contribute only slightly to the absolute risk of
disease [5]. These disease-associated mutations may undergo
positive selection if they are simultaneously associated with
relatively strongly beneficial traits. For example, the sickle cell
mutation in the Hemoglobin-B (HBB) gene was found to be the
target of positive selection due to its properties related to malaria
resistance, despite its simultaneous role in introducing sickle cell
disease [3]. It has also been recently shown that the variants in the
antiviral response gene IFIH1 associated with protection against
enterovirus infection simultaneously increase susceptibility to Type
1 Diabetes (T1D) [6]. In this case, the benefits of having variants of
the IFIH1 gene that increase susceptibility to T1D depend on the
prevalence of enterovirus infection. Having IFIH1 gene variants
increasing susceptibility to T1D may be considered advantageous
and undergo positive selection if the probability of being exposed
to the virus were high.
Rheumatoid Arthritis (RA) can be detected in human skeletal
remains, and likely originated from the Americas and spread to
Europe after the pre-Columbian era ended, possibly by a
microorganism or allergen that is a necessary trigger for the
disease [7]. This paves the way for selection to proceed strongly for
potential benefits associated with the genetic-basis of RA. Prior to
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RA, there would be no disadvantage to having mutations
associated with RA in European populations. Ultimately, the
cumulative contribution of such mutations with low effect sizes
may play a large role in causing the disease.
It is currently unknown how much of the genetic-basis of
complex disease originates from genetic mutations driven to
prevalence by positive selection pressures. Blekhman et al.
demonstrated that coding positions within disease associated genes
underlying a number of complex human diseases are more rapidly
evolving than coding regions of genes not associated with disease
[8]. This suggests that evolutionary changes and natural selection
may play a role in regions associated with complex disease.
We define a risk/susceptibility allele as the allele associated with
more disease cases in the GWAS data used for our study, while the
protective allele is necessarily present more often in healthy
controls. Finding positively selected risk-associated alleles in
complex human disease is challenging. It is easiest to learn more
about the origins and history of disease when a mutation
simultaneously confers a selective advantage while increasing
susceptibility to disease in the same environment. It becomes more
challenging when the risk-associated allele may falsely appear to be
the target of selection if it is linked to a very advantageous allele
due to linkage disequilibrium. To fully explain the origins of such
risk-associated alleles, the nearby target of positive selection must
first be identified.
An allele increasing susceptibility to disease in today’s
environment may have increased fitness only in an alternative
environmental context [9], which makes it difficult to determine
how (now absent) fitness-increasing properties can fully explain the
history and origins of disease. While it is well established that more
strongly deleterious mutations exhibit evolutionary profiles that
differ from more neutral forms of variation in the human genome,
it has been challenging to assess how much of a role natural
selection has played in weakly deleterious mutations [10]. In
previous studies excluding non-coding SNPs, it was shown that
SNPs within complex disease associated genes are likely to be
undergoing positive selection [11] [8], even in diseases having little
impact on fitness [12]. If weakly deleterious mutations rise to
prevalence via the positive selection of separate fitness increasing
traits, we expect to find positive selection within relatively weakly
deleterious mutations.
The first steps in addressing the issue of positive selection in
complex diseases (including Crohn’s Disease, Type 1, and Type 2
Diabetes) were taken in a study that scanned specific disease
associated SNPs for positive selection [10]. This study examined
an exclusive set of associated SNPs to avoid false associations, but
excludes many hidden associations found in moderate association
p-values. Consequently, while positive selection was found in
individual SNPs, the search for positive selection of the overall
genetic-basis of the each disease was inconclusive. A more
thorough approach with positive selection detection methods
proven to be more sensitive is warranted. Other approaches
employing evolutionary analysis to characterize the genetic basis of
disease are not applicable to complex disease. For example,
selective pressures acting on specific conserved codon positions are
used to predict deleterious mutations in human disease genes [13].
While evolutionary analysis of coding SNPs (cSNPs) within
conserved amino acid sequences is informative most often for
monogenic and Mendelian diseases, the same approach holds less
utility in the analysis of complex, polygenic disorders due to
association of many low-risk non-coding SNPs.
Modern approaches that incorporate haplotype structure have
more power to detect recent positive selection [14], making them
ideal for finding evidence of selection among complex diseases that
have only recently emerged in the human genome. Detecting
positive selection in loci associated with complex disease informs
on the evolutionary history of disease and narrows down the
search for positively selected components, possibly exposing the
presence of unknown advantageous functions associated with the
genetic basis of such diseases. These methods also indicate whether
selection is acting on the major or minor allele.
It has been shown that different diseases can share association to
the same SNPs, and that while one allele increases disease risk for
one disease, the other allele may decrease disease risk for another
[15]. By extending this principle, it is possible to determine
whether selecting for protection against a disease also selects for
increased risk for a separate disease.
Previous studies have focused on explaining the evolutionary
role of the most highly selected genes in the human genome [14],
[16], genes leading to monogenic disorders [17], or searching for
selection within a handful of candidate genes [18], [19]. This study
explores the role of selection across all SNPs moderately (p-value
,0.05) associated with seven complex diseases characterized by
the Wellcome Trust Case Control Consortium (WTCCC) within
the context of population-based evolutionary histories [20]. In
particular, this study investigates i) the relative patterns of positive
selection across the WTCCC disease panel, ii) differences in
positive selection signal strength in risk and protective alleles of
disease-associated SNPs, and iii) proposes a method for identifying
regions of interest likely to be strongly associated with disease
despite modest association p-values from GWA studies. Insights
into the selective pressures acting on disease-associated SNPs
inferred from GWA studies offer a novel perspective that promises
to augment the biological interpretation of the results and
potentially serve as a complementary method for prioritizing
disease-associated SNPs for follow-up validation studies. The
overall aim of this study is to find evidence of positive selection
within the genetic-basis of complex disease.
Results
The Wellcome Trust Case Control Consortium (WTCCC) only
identified twenty-four independent loci associated with the seven
diseases at p ,5610
27; however, we expected there to be many
additional associated loci likely hidden among SNPs with
moderate p-values of association. Therefore, the association p-
value threshold of 0.005 was used throughout this study in order to
capture a larger proportion of these hidden associations, and any
SNP with a p-value below this threshold is referred to as
‘‘associated’’. We expect an increasing proportion of false
associations as the p-value threshold is increased. Every allele of
each associated SNP was evaluated for positive selection using
both the integrated Haplotype Score (iHS) [14] and Long Range
Haplotype (LRH) [21] methods, and was normalized with respect
to the allele frequency and the ancestral or derived allele state (see
Methods). Normalizing procedures are performed on all positive
selection scores before any data analysis takes place. A different
distribution of positive selection scores using both iHS and LRH is
observed when the data is partitioned into distinct allele frequency
scores as well as ancestral or derived allele states. This occurs
because higher frequency alleles are older and their surrounding
regions have had more time to undergo recombination, which
makes it harder to detect positive selection. Likewise, ancestral
alleles are older and have more recombination in the surrounding
region. We also control for linkage disequilibrium by partitioning
the entire genome into haplotype blocks and only including the
SNP most strongly associated with disease in our analysis prior to
Evolution in Complex Diseases
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positive selection event twice (see Methods).
The number of SNPs moderately associated with each of the
seven studied diseases is shown in Table 1. Out of the 1896 SNPs
with moderate association with Type 1 Diabetes (T1D; p-values
,0.005), there are 80 SNPs with strong evidence for selection,
defined as having an absolute iHS score over 2.2. Calculating iHS
values for each SNP yields two scores, one for each allele [14]. It is
thus possible to further divide SNPs into those where selection is
stronger for the allele increasing susceptibility to disease (i.e. the
risk allele) and those in which selection favors the other
‘‘protective’’ allele. As shown in Table 1, we found surprising
asymmetry in the selection of protective alleles compared to risk-
associated alleles for certain diseases. We expect the same number
of risk and protective alleles to be selected under the neutral
model; in contrast to this, 58 alleles associated with increased risk
of T1D exhibit selection, compared to 22 for protective alleles,
revealing an asymmetrical distribution (binomial test p-value
7.01610
25 against the null hypothesis of equal likelihood of risk
and protective alleles to show stronger positive selection).
Crohn’s Disease (CD) shares this asymmetrical distribution in
the opposite direction, with 34 of 47 associated and positively
selected SNPs exhibiting selection towards protective alleles
(binomial test p-value 3.09610
23). Bipolar Disorder (BD), like
CD, also shows asymmetry in selecting for protective alleles, with
18 out of 22 alleles showing stronger selection for the protective
allele. The findings in Table 1 were reproduced using the LRH
test to detect positive selection yielding results matching very
closely (see Table S1).
Figure 1 shows the cumulative mean positive iHS selection score
for SNPs at or stronger than threshold p-values of association, for
all seven diseases. Interestingly, we find the strongest selected SNPs
are found among the most significantly associated SNPs for T1D
(Fig. 1a). Rheumatoid Arthritis (RA) also shows a concentration of
high selection scores within the most significantly associated SNPs,
as does Type 2 Diabetes.
The gray regions in Figure 1 represent neutral selection, made
up of 1000 simulated control diseases having a random
distribution of positive selection scores across SNPs with low p-
values of association. In order to create each neutral control
disease, all sets of SNPs from each of the 7 diseases were
combined. From this combined set of SNPs, 86,972 SNPs were
randomly drawn (matching the size of the data set for an LD
controlled WTCCC disease). Each individual control disease then
undergoes a random permutation of all of its positive selection
scores, thereby producing a random distribution of positive
selection scores in SNPs having low association p-values.
While Table 1 shows that three diseases show bias towards
selection of risk-associated alleles or protective alleles, it does not
show whether the selection itself is stronger among the risk
associated alleles or protective alleles. Figures 1b and 1c show that
the asymmetry of evidence for positive selection in risk and
protective alleles shown in Table 1 is present within the most
significantly associated SNPs.
Surprisingly, T1D shows the strongest selection pressure for its
risk-associated alleles (Figure 1b), compared to the other six
diseases and compared to its protective alleles (Figure 1c). RA and
Type 2 Diabetes (T2D) also show strong selective pressure for both
its risk-associated and protective alleles, but this selection is
symmetrical, consistent with the results in Table 1. Table 1 shows
that selection in CD more frequently acts on protective alleles;
consistent with this, Figures 1b and 1c show that among protective
alleles, there is a very strong signal of positive selection compared
to risk-associated CD alleles (which show no deviation from the
gray neutral region).
Analyzing GWA studies in the context of selection can
complement and augment the standard p-value of association
and aid in the identification and characterization of causal loci for
follow-up validation studies. Figure 2 places the SNPs on
chromosome 6 associated with T1D within their evolutionary
context. Deviations from the gray control region are observed in
favor of susceptibility alleles in two regions, one in the HLA region
and another towards the right side of the figure. T1D SNPs show
more selection for risk than for protective alleles in the HLA region
(left peak in Fig. 2). Another peak of selection is seen within a
region with the positively selected SNP rs6917204 in linkage
disequilibrium with the moderately T1D-associated SNP
rs7760387. Many true associations are likely hidden among those
SNPs with moderate p-values of association produced in GWA
studies. Since selection is exclusively detectable in risk alleles
within some moderately associated regions, it may be reasonable
to up-weight the importance of these kinds of SNPs for follow-up
deep sequencing and functional validation.
An inclusive list of all genes containing associated SNPs showing
signs of recent positive selection is included in Table S2. In order
to produce an inclusive list of associated SNPs that are likely
Table 1. Analysis of selection within risk-associated and protective alleles.
Disease
Number of SNPs associated
with disease with p ,0.005
Number of SNPs associated with
disease with p ,0.005 and |iHS| .2.2
Risk Allele Is More
Selected
Protective Allele is More
Selected
Binomial Test
p-value
T1D 1896 80 (4.22%) 58 22 7.01610
25
T2D 1632 42 (2.57%) 16 26 0.16
CD 1658 47 (2.83%) 13 34 3.09610
23
CAD 1583 37 (2.34%) 21 16 0.51
RA 1695 48 (2.83%) 27 21 0.47
HT 1578 33 (2.09%) 17 16 1.00
BD 869 22 (2.53%) 4 18 4.34610
23
Type 1 Diabetes risk alleles show significantly more selection than protective alleles, while Crohn’s Disease and Bipolar Disorder show the opposite trend. We considered
the set of moderately associated SNPs (p-value ,0.005) across seven diseases studied by the Wellcome Trust Case Control Consortium. In Type 1 Diabetes, Crohn’s
Disease, and Bipolar Disorder, we see significant bias towards strong selection (defined as having an absolute iHS score .2.2) among these moderately associated SNPs.
Each SNP represents a risk allele (allele increases susceptibility to disease) and a protective allele (the other allele). Among moderately selected SNPs associated with
Type 1 Diabetes, 58 are SNPs in which the risk allele shows more selection, and only 22 are SNPs in which the protective allele shows more selection, showing that risk
alleles are more likely to have undergone positive selection (p-value =7.01610
25).
doi:10.1371/journal.pone.0012236.t001
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0.005 is maintained. In addition to meeting this threshold, all
SNPs in Table S2 have an absolute iHS score above 1.645 and an
LRH score below 0.05, representing SNPs that pass the top 95
th
percentile for both iHS and LRH. Two missense mutations show
up in this list for T1D, including MOGS (in SNP rs1063588), which
encodes the first enzyme in the N-linked oligosaccharide
processing pathway. A second SNP (rs1525791) within the
POU6F2 gene shows up for four different diseases: T1D, T2D,
CD, and BD. The selected allele in this SNP represents the risk-
associated allele for all four diseases. Table S3 shows all selected
SNPs appearing in more than one disease.
Discussion
Consistent with previous studies, we find positive selection is
acting on loci associated with complex disease, when viewed from
the perspective of Genome-Wide Association Studies (Fig. 1).
While one might expect positive selection to eradicate risk-
associated mutations and favor protective variants, like we find for
CD (Table 1), we also surprisingly find the strongest selection
working in favor of risk-associated alleles in both T1D and RA
(Fig. 1b and Table 1).
It may be the case that some risk alleles are positively selected
individually or as components of an abstract biological function
Figure 1. Selection in 7 WTCCC diseases. Comparison of selection pressures reveals stark heterogeneity across the 7 diseases studied. The x-axis
represents the p-value of association cutoff used for each disease when calculating the mean iHS score (y-axis). Figure 1a shows Type 1 Diabetes and
Rheumatoid Arthritis have strong evidence of positive selection. Type 2 Diabetes shows signs of positive selection only in the most strongly
associated SNPs (left side of figure). Figures 1b and 1c expose differences in selection of risk-associated and protective alleles. Crohn’s Disease shows
stronger positive selection of protective alleles versus risk alleles. Like Type 1 Diabetes, Hypertension shows stronger selection for risk alleles. The gray
regions represent a neutral random region used as a control, created by randomizing the data (see Methods).
doi:10.1371/journal.pone.0012236.g001
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implies that there may be hidden benefits associated with some of
the RA and T1D positively selected risk alleles. Positive selection
in favor of risk alleles may occur if these alleles lead to an
advantageous trait in an alternative environmental context (e.g.
protection from pathogens). It is worth mentioning that there must
be some reason why the ancestral allele characterized ancient
populations in the first place in the cases where the derived allele
Figure 2. Selection of Type 1 Diabetes risk associated alleles in chromosome 6. Selection of associated alleles in chromosome six indicates
that selection occurs more often on risk associated alleles versus protective alleles. The y-axis in the top plot represents how strongly each SNP is
associated with Type 1 Diabetes. The y-axis in the bottom two plots represent how confident we can be that susceptibility alleles and protective
alleles have been selected in each chromosomal region. The HLA (purple) region contains the strongest signs of positive selection for susceptibility
alleles, yet the signal is within the neutral region for protective alleles. The second peak on the right side of the figure shows selection favors risk
alleles in a region only moderately associated with the disease. Such asymmetry in selecting for risk-associated alleles suggests that SNPs in this
region are more likely to be associated with the disease than the p-values suggest. Similar scans for regions moderately associated with diseases
containing mutually exclusive selection of risk or protective disease alleles could be used to find novel associations. The gray regions in the bottom
two graphs represent random neutral regions produced by randomizing the data (see Materials and Methods S1 for details).
doi:10.1371/journal.pone.0012236.g002
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explanations for this. Possibilities include genetic drift driving a
benign mutation to fixation in ancient populations, only to have
this benign mutation become deleterious relative to a different
allele in a modern environment. Another possibility is that an
ancient environment may have also caused the ancestral allele to
undergo positive selection, only for a modern environment to
induce the ancestral allele to undergo negative selection.
There is recent evidence suggesting that protection from
pathogens helps explains why positive selection has occurred for
T1D susceptibility alleles. Rare variants in the antiviral response
gene IFIH1 have recently been shown to be protective against
T1D [6]. The protective alleles are functionally deleterious to
IFIH1, effectively reducing the ability to mediate an immune
response against enterovirus infection. Recent immunological
studies of beta cells in patients recently diagnosed with T1D have
shown an abundance of enteroviral capsid proteins in the islet cells
of affected patients, whereas the protein is found to be scarce
among the beta cells of healthy controls [22]. It is plausible that
signatures of recent positive selection in T1D and other
autoimmune diseases are due to an overactive immune system
driven at least in part by an adaptive immune response to viruses.
Due to the evolutionary trajectory of T1D favoring susceptibility
alleles and the severe effect on fitness in afflicted individuals, we
would expect that this evolutionary event would have happened
recently in human evolution. While T1D is rapidly fatal without
insulin therapy, there was likely a net selective pressure favoring
intense immune responses to enterovirus, even with T1D as an
occasional consequence.
RA has been found to originate from Native American
populations from the Green River region in west central
Kentucky. There are verified cases of RA in this population as
far back as 6,500 years ago. No signs of RA were found in 63
archaeological sites bordering the original area in central
Kentucky, where it was originally found [7]. Yet, there is
documented spread in America over time. The first evidence of
RA outside the original ‘‘catchment’’ area occurs in western Ohio
about 1,100 to 800 years ago. At the same time, virtually no
incidence of RA in other parts of the world has been found
towards the end of the pre-Columbian era in 1785. This suggests
that some environmental factor, perhaps a microorganism or
allergen, might play a critical role in the cause of RA [7]. Our
analysis reveals that there is a huge disparity in positive selection
scores between alleles increasing and decreasing susceptibility to
RA. Susceptibility alleles show very strong signs of positive
selection, while alleles decreasing susceptibility are nearly devoid
of any signs of positive selection (Fig. 1b–1c). The history of RA
helps explain why susceptibility alleles show signs of positive
selection in European-derived populations (Fig. 1). Since RA was
non-existent in these populations during the pre-Columbian era,
there were probably no disadvantages to selecting for the genetic-
basis of RA. Indeed, there may have been many benefits
associated with selecting for RA susceptibility alleles. Tuberculosis
is responsible for millions of deaths worldwide in recent human
history, with one in four deaths caused by tuberculosis in Western
Europe in the 19
th century alone. It is suspected that this disease
has historically acted as a powerful selective force. There is a stark
correlation between populations having higher incidence of
tuberculosis also having lower incidence of RA, and vice versa.
It has been speculated that genetic variants enhancing resistance to
tuberculosis underwent positive selection and provide the genetic
basis for RA susceptibility today [9]. Our analysis is completely
compatible with this theory, since we produce evidence that RA
susceptibility alleles have undergone positive selection. In addition,
tumor necrosis factor inhibitors alleviate symptoms of RA while
simultaneously increasing the risk of infection from tuberculosis,
Myobacterium marinum tenosynovitis, fungal infection, and other
opportunistic infections [23], [24], [25], [26], [27]. It is clear that
factors increasing susceptibility to RA also decrease susceptibility
to infectious disease. RA and T1D are known to share associated
variants [28], [29]. This may partially explain why there is a small,
but detectable signal of positive selection in alleles decreasing
susceptibility for RA. The evolutionary history of RA is unique in
that a precise date of introduction of RA into European-derived
populations has been established. We have shown that strong
positive selection of RA susceptibility alleles is observed, most
likely due to altered ability to fight infectious disease without
increasing the risk of RA itself until the pre-Columbian era ended.
Not much is known about the history of Crohn’s Disease (CD)
as it does not leave unambiguous signs in skeletal remains, as is the
case with RA. It is known that the incidence of CD increased
during the 19
th century in industrialized countries. The rate of CD
increases as under-developed countries become more industrial-
ized (e.g. Japan and Brazil) [30]. Many bacteria are implicated in
CD, including anaerobic organisms, paratuberculosis, Boeck’s
sarcoid, and mycobacteria. Mycobacterial paratuberculosis infection of
the terminal ileum in cattle (Johne’s disease) resembles also closely
resembles Crohn’s disease, which has suggested possible bacterial
associations with CD [30]. Unlike RA and Type 1 Diabetes, CD
shows more positive selection for alleles decreasing susceptibility to
disease than for those increasing susceptibility. It may be the case
that CD is in fact an ancient disease, the incidence of which was
reduced due to natural selection against CD, only to see
resurgence due to the advent of modern environments. However,
many other possible scenarios could explain our findings,
including shared genetic variants with a disease or trait that has
undergone negative selection. CD is unique in the sense that while
selection is detected as in RA and T1D, alleles decreasing
susceptibility for CD are under positive selection, indicating a very
different evolutionary history.
We acknowledge several limitations in our analysis. Controlling
for LD by selecting only one SNP in each haplotype block after
partitioning the genome may have complications in some regions
of the genome. Haplotype blocks intuitively capture LD, but lack
of complete haplotype block coverage (the fraction of the genome
that is found neatly within haplotype blocks) complicates this
approach [31]. More complex methods to control for LD will be
considered for future works requiring a similar analysis. Another
complicating issue is that both iHS and LRH belong to the same
class of analytical methods for detecting selection, and it is not
surprising that they indicate similar results. Yet, it has been shown
that these two methods are in some ways complementary as they
are better at detecting selected SNPs at different allele frequencies
[16]. Overall, the results under iHS match the results produced
with LRH with some changes in the magnitude of selection
pressures on some diseases leading to more diseases appearing in
the random neutral region in Fig 1 versus Figure S1 (more details
on limitations in Materials and Methods S1). We acknowledge that
it is unknown whether or not the most associated SNPs are
causative; leading to confusion when we discuss selection for risk-
associated alleles as the causal SNP may show the opposite
selection pattern, that is, stronger selection of the protective allele.
While this is certainly a possibility, it is unlikely to occur often. If a
SNP has a very low p-value of association to a disease due to its
proximity to the causative allele, it implies strong LD between the
two SNPs. Due to strong LD, the risk-associated allele between the
non-causative and the causative SNPs are more likely to be on the
same haplotype block, making the risk-associated allele in a SNP
Evolution in Complex Diseases
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addition, it should be noted that all discussion on the reasons for
positive selection acting on these diseases necessarily remains
speculation.
In summary, we observed stark heterogeneity in the overall
patterns of positive selection across seven diseases. We find that the
SNPs associated with T1D, RA, and CD show strong signs of
positive selection. We also find that positive selection favors risk-
associated alleles in T1D and protective alleles in CD, which is
indicative of an evolutionary trajectory towards increasing and
decreasing risk, respectively. In addition, we have demonstrated
that selection analyses of GWAS results can complement and
augment the basic p-value of association attributes (Fig. 2) as many
regions appear to exclusively favor selection of risk or protective
alleles.
Methods
In EHH (extended haplotype homozygosity) based positive
selection methods, there are two selection scores for each SNP (one
for each allele). Both iHS and LRH are based on the EHH
calculation. These two methods, and variants thereof have been
applied to uncover signals of positive selection within genes related
to susceptibility and resistance to infectious disease [16], innate
and adaptive immunity [32], LDL cholesterol levels [33], and
autoimmune disorders [34]. This method exploits the principle
that alleles in relatively larger and over-represented haplotype
blocks imply positive selection. These two methods produce biased
scores depending on the allele frequency and ancestral/derived
allele state. These limitations were overcome by performing Z-
score normalization and rank normalization of each iHS and LRH
measurement, respectively. Each allele of each SNP was grouped
with other alleles having the same allele frequency in addition to
having the same ancestral/derived state prior to performing Z-
score (iHS) and inverse rank (LRH) normalization. All references
to iHS and LRH score reference their normalized values.
The WTCCC study used the Affymetrix GeneChip 500K Array
set to conduct a GWA study made up of two European cohorts for
each disease. These include 2000 affected individuals for each of
the seven diseases as well as a common control group of 3000
individuals. This study exploits the existence of hidden associations
by including moderately associated SNPs. While this will
undoubtedly capture hidden associations, diminishing returns of
these ‘‘hidden associations’’ are expected as one increases the p-
value (Fig. 1). The entire project pipeline is shown in Figure 3. We
took all associated SNPs from the 7 diseases studied by the
WTCCC using high-density assays [20] and used both iHS and
LRH to probe for evidence of positive selection in these SNPs
using haplotype information from the population having Europe-
an ancestry in Phase 2 of the International HapMap project [35].
For every SNP showing association with disease (p-value ,0.005)
that has recently undergone positive selection (|iHS| .2.2), we
determined whether the selected allele within the SNP is
associated with susceptibility to disease versus protection from
disease (Table 1 and Table S1). Figure 4 shows how risk versus
protective SNPs are partitioned in this study.
In every case, the positive selection score assigned to a SNP is
simply the score from the major and minor alleles showing the
strongest signs of positive selection. As mentioned, there are two
selection scores for each SNP, one for each allele. This makes it
possible to investigate positive selection of a disease’s risk-
associated alleles separately from its protective alleles. In addition
to controlling for allele frequency and for the ancestral/derived
allele state, it is important to take into consideration whether or
not a disease appears to be exhibiting positive selection due to a
few high-scoring non-independently associated regions in Linkage
Disequilibrium (LD). This analysis relies on the independence of
each positive selection score measurement. In order to overcome
Figure 3. Project pipeline. The HapMap and WTCCC data sets are combined and partitioned to derive the data sets used for this study. First, the
HapMap data set is filtered (SNPs with MAF ,0.05 are excluded). iHS and LRH scores are then calculated for each SNP, which are Z-score and inverse
rank normalized with respect to allele frequency and ancestral/derived allele state. The data is then merged with a WTCCC disease SNP data set after
the ‘‘risk’’ allele has been extracted from the WTCCC SNP data set. This leads to 4 distinct SNP datasets; i) scored CEU HapMap SNPs, ii) the
intersection of WTCCC SNPs and HapMap SNPs, iii) SNPs in which the susceptibility allele shows more selection iv) SNPs in which the protective allele
show more selection. This data processing pipeline is used on all 7 WTCCC diseases, resulting in distinct data sets, which are then probed for
disparities in positive selection.
doi:10.1371/journal.pone.0012236.g003
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calculations, the entire genome was partitioned into haplotype
blocks using HapBlock software [36]. Haplotype blocks can be
defined as regions of high |D’| or low haplotype diversity. The
‘‘Haplotype Diversity’’ method is used for partitioning the data
into haplotype blocks [37] (more details provided in Materials and
Methods S1). For each haplotype block, only the SNP most
strongly associated with each of the 7 diseases (leading to a
different data set for each disease) is chosen for this study, along
with its corresponding iHS and LRH score (see Materials and
Methods S1).
Randomized WTCCC and HapMap data was produced to
detect deviations from neutral selection in Fig. 1 and Fig. S1. Each
SNP comprising the 1000 neutral diseases (along with its positive
selection score) are picked at random from each of the 7 diseases
until the number of SNPs in each disease matched the number of
SNPs in a WTCCC disease. The entire complement of the
WTCCC disease panel resulting after the normalization and
filtering procedures discussed was used to compute each random
disease. Following this random selection of SNPs, the entire
combined list of SNPs from the 7 diseases was randomly
reassigned a positive selection score from this same combined list
of SNPs, thereby creating 1000 ‘‘random neutral diseases’’ that
have a random distribution of selection scores in associated SNPs.
Figure 1 and Fig. 2 contain random neutral regions produced with
this set of 1000 random diseases (see Materials and Methods S1 for
more details).
Data for the seven diseases studied was obtained from the
WTCCC1 data set [20]. WTCCC SNPs were intersected with
CEU (Utah population) HapMap Phase II data (release 23a; only
including autosomes). With the WTCCC data set, it is possible to
deduce which allele within an associated SNP is increasing
susceptibility to disease by looking at the genotype of the control
group as well as those affected by the disease. Since LRH and iHS
give scores for each allele of every SNP, we use the associated allele
for each disease (derived from the WTCCC data set) and each
allele’s LRH and iHS scores (computed from the HapMap data set)
in order to assess whether the evolutionary trajectory is towards
increased or decreased susceptibility to the diseases studied. The
HapMap data adds frequency and haplotype data to each SNP
included in the WTCCC study. Intersecting the HapMap and
WTCCC data sets yielded 352,191 Type 1 Diabetes, 352,202 Type
2 Diabetes, 352,199 Rheumatoid Arthritis, 352,200 Hypertension,
352,198 Crohn’s Disease, 352,198 Coronary Artery Disease, and
332,576 Bipolar Disorder SNPs. These SNPs were then normalized
and filtered to control for LD effects. Finally, they are partitioned as
shown in Fig. 4. Emphasis is placed on SNPs associated with each
disease (defined as p-value ,0.005 for this study). Among these,
positively selected SNPs were identified (iHS .2.2 and normalized
LRH score ,0.01). Such positively selected SNPs were tested to see
if the risk and/or protective alleles have recently undergone
positive selection. Ancestral and derived alleles were determined by
downloading DBSNP [38], which uses a method that derives the
ancestral allele by comparing human DNA to chimpanzee DNA
[39]. This study makes use of data generated by the Wellcome
Trust Case Control Consortium. A full list of the investigators who
contributed to the generation of the data is available from www.
wtccc.org.uk. Funding for the Wellcome Trust Case Control
Consortium was provided by the Wellcome Trust under award
076113. Version WTCCC1 of the dataset was used for this study
[20].
Supporting Information
Materials and Methods S1 Materials and methods explaining
limitations of this study, replication of the main results using LRH,
and a list of SNPs associated with more than one disease showing
some signs of selection.
Found at: doi:10.1371/journal.pone.0012236.s001 (0.04 MB
DOC)
Figure 4. Partitioning the data set. The entire set of SNPs present in both the WTCCC and HapMap data sets was partitioned into five different
categories. This study emphasizes associated SNPs partitioned into risk-associated selection and protective selected SNPs. The proportion of SNPsi n
these categories at cutoffs for selection and association (|iHS| .2.2 and rank normalized LRH score ,0.01) is explored and used to test for differences
in selection pressures among associated SNPs (p-value ,0.005). Within associated SNPs, selection pressures between risk-associated selection (SNPs
in which stronger selection is observed for the risk-associated allele), and protective selection are explored.
doi:10.1371/journal.pone.0012236.g004
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PLoS ONE | www.plosone.org 8 August 2010 | Volume 5 | Issue 8 | e12236Figure S1 Comparison of selection pressures reveals differences
across the 7 diseases studied. The x-axis represents the p-value of
association cutoff used for each disease when calculating the mean
rank normalized LRH score (y-axis). Type 1 Diabetes shows
extremely strong signs of positive selection. Crohn’s Disease,
Rheumatoid Arthritis, and Hypertension also exhibit evidence of
positive selection. Figures S1b-S1c expose differences in the
magnitude of selection strength. Crohn’s Disease shows stronger
positive selection of protective alleles versus susceptibility alleles.
Hypertension shows positive selection almost exclusively for risk
alleles. The gray regions represent a neutral random region used
as a control which was made by randomizing the data (see
Methods).
Found at: doi:10.1371/journal.pone.0012236.s002 (1.95 MB TIF)
Table S1 Alleles of SNPs associated with disease (p-value
,0.005) can either be SNPs in which the susceptibility allele
shows more selection than the protective allele (risk SNPs) or SNPs
in which the protective allele shows more selection (protective
SNPs). When the intersection of Type 1 Diabetes associated SNPs
(p-value 0.005) and strongly selected SNPs (LRH ,0.01) are
considered, 23 are SNPs in which the risk allele shows more
selection than the protective allele, and only 8 are SNPs in which
the protective allele shows more selection. This shows that risk
alleles are more likely to have undergone positive selection (p-
value =0.01).
Found at: doi:10.1371/journal.pone.0012236.s003 (0.04 MB
DOC)
Table S2 In order to produce an inclusive list of all disease
associated SNPs that have recently undergone positive selection,
all associated SNPs (p-value ,0.005) having both a rank
normalized LRH score below 0.05 and an iHS score greater than
1.645 (representing the 95th percentile in both LRH and iHS) are
shown. SNPs in linkage disequilibrium with the SNPs appearing in
these tables were not listed.
Found at: doi:10.1371/journal.pone.0012236.s004 (0.16 MB
DOC)
Table S3 Five of the SNPs listed in Table S2 appear in more
than one disease. In particular, rs1525791 appears in four of the
seven WTCCC diseases and the risk-associated allele in this SNP
shows more selection than the protective allele. This is in contrast
to rs204989, where the susceptibility allele for Type 1 Diabetes
and the protective allele for Rheumatoid Arthritis are under
selection.
Found at: doi:10.1371/journal.pone.0012236.s005 (0.04 MB
DOC)
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